692 related articles for article (PubMed ID: 16815654)
1. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
2. Predicting the physical state of spray dried composites: salbutamol sulphate/lactose and salbutamol sulphate/polyethylene glycol co-spray dried systems.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2004 Apr; 273(1-2):171-82. PubMed ID: 15010141
[TBL] [Abstract][Full Text] [Related]
3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
Zeng XM; MacRitchie HB; Marriott C; Martin GP
Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
[TBL] [Abstract][Full Text] [Related]
4. Aerosolisation of beclomethasone dipropionate using spray dried lactose/polyethylene glycol carriers.
Gilani K; Rouholamini Najafabadi A; Barghi M; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2004 Nov; 58(3):595-606. PubMed ID: 15451534
[TBL] [Abstract][Full Text] [Related]
5. The enhanced aerosol performance of salbutamol from dry powders containing engineered mannitol as excipient.
Kaialy W; Martin GP; Ticehurst MD; Momin MN; Nokhodchi A
Int J Pharm; 2010 Jun; 392(1-2):178-88. PubMed ID: 20363301
[TBL] [Abstract][Full Text] [Related]
6. Engineered mannitol as an alternative carrier to enhance deep lung penetration of salbutamol sulphate from dry powder inhaler.
Kaialy W; Momin MN; Ticehurst MD; Murphy J; Nokhodchi A
Colloids Surf B Biointerfaces; 2010 Sep; 79(2):345-56. PubMed ID: 20537870
[TBL] [Abstract][Full Text] [Related]
7. Agglomerated novel spray-dried lactose-leucine tailored as a carrier to enhance the aerosolization performance of salbutamol sulfate from DPI formulations.
Molina C; Kaialy W; Chen Q; Commandeur D; Nokhodchi A
Drug Deliv Transl Res; 2018 Dec; 8(6):1769-1780. PubMed ID: 29260462
[TBL] [Abstract][Full Text] [Related]
8. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
9. Production of salbutamol sulfate for inhalation by high-gravity controlled antisolvent precipitation.
Chiou H; Li L; Hu T; Chan HK; Chen JF; Yun J
Int J Pharm; 2007 Feb; 331(1):93-8. PubMed ID: 17052870
[TBL] [Abstract][Full Text] [Related]
10. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
Thi TH; Danède F; Descamps M; Flament MP
Eur J Pharm Biopharm; 2008 Sep; 70(1):380-8. PubMed ID: 18504120
[TBL] [Abstract][Full Text] [Related]
11. Electrostatic characterisation of inhaled powders: effect of contact surface and relative humidity.
Elajnaf A; Carter P; Rowley G
Eur J Pharm Sci; 2006 Dec; 29(5):375-84. PubMed ID: 16952450
[TBL] [Abstract][Full Text] [Related]
12. The effect of vehicle on physical properties and aerosolisation behaviour of disodium cromoglycate microparticles spray dried alone or with L-leucine.
Najafabadi AR; Gilani K; Barghi M; Rafiee-Tehrani M
Int J Pharm; 2004 Nov; 285(1-2):97-108. PubMed ID: 15488683
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.
Traini D; Young PM; Jones M; Edge S; Price R
Eur J Pharm Sci; 2006 Feb; 27(2-3):243-51. PubMed ID: 16330191
[TBL] [Abstract][Full Text] [Related]
14. Particle engineering using sonocrystallization: salbutamol sulphate for pulmonary delivery.
Dhumal RS; Biradar SV; Paradkar AR; York P
Int J Pharm; 2009 Feb; 368(1-2):129-37. PubMed ID: 18996462
[TBL] [Abstract][Full Text] [Related]
15. Characterisation and deposition studies of recrystallised lactose from binary mixtures of ethanol/butanol for improved drug delivery from dry powder inhalers.
Kaialy W; Martin GP; Ticehurst MD; Royall P; Mohammad MA; Murphy J; Nokhodchi A
AAPS J; 2011 Mar; 13(1):30-43. PubMed ID: 21057906
[TBL] [Abstract][Full Text] [Related]
16. Preparation and release of salbutamol from chitosan and chitosan co-spray dried compacts and multiparticulates.
Corrigan DO; Healy AM; Corrigan OI
Eur J Pharm Biopharm; 2006 Apr; 62(3):295-305. PubMed ID: 16314079
[TBL] [Abstract][Full Text] [Related]
17. Effect of milling and sieving on functionality of dry powder inhalation products.
Steckel H; Markefka P; teWierik H; Kammelar R
Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
[TBL] [Abstract][Full Text] [Related]
18. The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.
Kaialy W; Martin GP; Larhrib H; Ticehurst MD; Kolosionek E; Nokhodchi A
Colloids Surf B Biointerfaces; 2012 Jan; 89():29-39. PubMed ID: 21962946
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the physical properties of spray-dried stabilised lysozyme particles.
Liao YH; Brown MB; Quader A; Martin GP
J Pharm Pharmacol; 2003 Sep; 55(9):1213-21. PubMed ID: 14604464
[TBL] [Abstract][Full Text] [Related]
20. Excipient-free nanoporous microparticles of budesonide for pulmonary delivery.
Nolan LM; Tajber L; McDonald BF; Barham AS; Corrigan OI; Healy AM
Eur J Pharm Sci; 2009 Jul; 37(5):593-602. PubMed ID: 19463948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]